https://melatoninagonist.com/t....he-apoe-%ce%b54-puts
The study leveraged data stemming from a series of cross-sectional, population-based surveys undertaken within the canton of Geneva, Switzerland, from 2005 to 2019. The rates of dyslipidaemia, concerning prevalence, awareness, treatment, and control, saw marked changes between 2005 and 2019. Specifically, prevalence demonstrated 460% and 349% (p 0.0001) increases, awareness increased by 670% and 773% (p = 0.124), treatment by 400% and 199% (p &
Like
Comment
Share
